Most of what this dossier holds about Tetrasilver Tetroxide (Ag₄O₄) comes from patents and sales pages by or about Marvin Antelman. This article covers a different kind of document: an open-access review in the peer-reviewed literature, "Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation", by Sergey V. Gudkov, Dmitriy A. Serov, Maxim E. Astashev, Anastasia A. Semenova and Andrey B. Lisitsyn. It was received on 13 July 2022 and accepted on 4 August 2022, published under a CC BY licence, and funded by the Russian Ministry of Science and Education (Grant Agreement 075-15-2020-775).
The review's main text does not discuss Antelman or tetrasilver tetroxide. It matters here because it shows what the published laboratory record says about silver oxides as antimicrobials. That gives a reference point for judging the stronger and more unusual claims made for tetrasilver tetroxide.
What the review sets out to do
The authors start from antibiotic resistance and the search for new antimicrobial agents. They argue that nanoparticles of metals and metal oxides are leading candidates. Their focus is silver(I) oxide, Ag₂O, in nanoparticle form. They pull together published work on how the particles are made, which organisms are reported to be sensitive, how the particles are thought to act, and how their activity might be improved. The core of the paper is a table of 58 entries. Each entry is one published study, giving the material, particle size, test organisms, type of effect, minimum inhibitory or bactericidal concentration (MIC/MBC) and the main result.
The authors describe part of their work as a meta-analysis: they plot MIC against particle size and against synthesis method, comparing methods with the Mann–Whitney test. The document does not describe a systematic search method for finding studies, so its conclusions depend on which studies the authors chose to include.
What does it kill, and does cell-wall type matter?
The table spans bacteria, fungi and, in one case, a virus. The authors tally at least 53 sensitive microbial species, made up of 21 Gram-negative bacteria, 15 Gram-positive bacteria and 17 fungi. Familiar laboratory and hospital organisms dominate the list: Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Bacillus subtilis, Candida albicans and Aspergillus. Drug-resistant strains, methicillin-resistant S. aureus among them, appear in several entries. The single viral result comes from a silver-oxide coating on glass, which is reported to lower SARS-CoV-2 titres on the treated surface after 1 and 24 hours.
Cell-wall type is where the collected studies pull in different directions. Gram-negative and Gram-positive bacteria have differently built envelopes, and the authors say they had anticipated a marked difference in sensitivity. The table does not deliver one. Some entries find Gram-negative bacteria more affected, others find the reverse, several report no difference, and two conclude that the particular species counts for more than its Gram group. The authors read the near-even split of sensitive species between the two groups as pointing to a general, rather than wall-specific, mode of action.
How consistent are the findings?
Most entries report that the particles slow or stop growth rather than kill outright. By the authors' count, about 75% of studies describe bacteriostatic activity and about 25% bactericidal activity, a 1:3 balance they compare with iron oxide and ZnO nanoparticles. Fungi lean further towards inhibition, with 85% of studies reporting fungistatic effects and 15% fungicidal ones; the authors attribute this to eukaryotic cells coping better with the genotoxic effects of metal ions.
The concentrations are far from uniform. Listed MICs run from about 0.1 µg/mL to tens of mg/mL, depending on formulation, particle size and organism. These are figures from in-vitro tests in culture dishes and are not treatment levels. Not every original study gave a concentration in comparable units: the review's authors calculated some values from the original studies' methods sections and mark them with an asterisk.
What is the proposed chemistry?
The authors begin from the established point that silver ions are themselves highly toxic to microbes, citing Ag⁺ killing Aspergillus niger spores at 5.5 × 10⁻⁵ M. This is the ion-based picture described in Antimicrobial Silver and the Oligodynamic Effect. They describe at least five mechanisms, which fall into three broad themes:
- Physical attack on the cell. Particles are said to attach to and breach the bacterial envelope, after which they may shed Ag⁰ and/or Ag⁺ inside the cell.
- Silver binding to biomolecules. Inside the cell, silver is described as latching onto sulfhydryl (SH) groups in proteins, which can knock out respiratory enzymes and starve the cell of ATP, and onto DNA, through phosphate groups and possibly the N7 atom of guanine, which would disrupt replication.
- Oxidative chemistry. Reactive oxygen species (ROS) produced along the way damage proteins and DNA and can break down cell walls and biofilms. Ag₂O particles are also reported to release O₂, and Ag₂O can strengthen the light-driven (photocatalytic) activity of composites with TiO₂ or ZnO.
Individual studies in the table tend to name one route for their own results, such as Ag⁺ release, ROS generation, inhibition of ATP synthesis or photocatalysis.
What changes the potency
According to the meta-analysis, smaller particles tend to show lower MICs against E. coli, which the authors put down to a larger surface-to-volume ratio releasing more silver species. Shape is reported to matter too, with one study finding cubic particles about twice as active as octahedral ones.
How the particles are made and dressed also shifts the numbers. The authors report that every modification they examined outperformed plain chemical precipitation. The modifications include polymer coatings such as chitosan, attaching drugs such as aspirin or moxifloxacin, composites with other oxides or graphene oxide, and "green synthesis" in plant extracts or microbial culture media. Moxifloxacin conjugation is reported to enlarge inhibition zones by 2–3 times.
The synthesis section describes Ag₂O formed when silver nitrate reacts with an alkali. Some variants add a strong oxidiser, which the review writes as K₂S₂O₄. This is a manufacturing step for the particles. It is a different role from the oxidiser "activation" that Antelman's patents describe (see Persulfate Activation).
Toxicity to human cells
The authors call the evidence on harm to human and other mammalian cells "ambiguous and constantly being enriched." Several studies report that Ag₂O or Ag/Ag₂O particles kill cancer cell lines, including MCF-7, A549 and HepG2, and other studies report apoptosis in normal lung and bronchial cell lines. Other studies report low toxicity: no effect on 3T3 fibroblasts, and in one case harm to eukaryotic cells only at concentrations 4–10 times higher than those that affect microbes. The authors suggest that much of the apparent biocompatibility comes from testing coated or composite particles rather than bare Ag₂O. The studies the review describes are laboratory work: cell cultures, microbial cultures and a rat wound-healing experiment.
Limits of the document
The review has clear limits as evidence:
- It relies on many small laboratory studies that use different methods, units and particle preparations. Some MIC values had to be recalculated.
- One cited study, on particles made with Vaccinium arctostaphylos extract, is marked as retracted in the paper's own reference list, yet it still appears in the data table.
- The authors' closing description of Ag₂O as a candidate "safe for humans and the environment" goes further than the mixed cytotoxicity evidence they present.
- The review is almost entirely about silver(I) oxide nanoparticles. Only a few entries involve AgO, the composition written as Ag₄O₄ in this dossier. One entry reports AgO particles of about 170 nm killing S. aureus at 20 µg/mL by breaking the cell wall. Another compares highly and poorly oxidised AgO/Ag/SnO₂ composites.
How it bears on the tetrasilver tetroxide claims
This document gives the dossier an outside baseline. Peer-reviewed laboratory work does support antimicrobial activity for silver oxides, including the higher oxide AgO. The mechanisms the authors describe are ion release, protein and DNA binding, oxidative stress and photocatalysis. None of them involves the discrete electron emission that "electrocutes" pathogens, which is the central idea of Electron Jumping Compound / Molecular Battery Claim. The review also shows how strongly activity depends on particle size, shape, coating and organism. A single product-level claim for Ag₄O₄ would need to specify all of these to be testable.
The review neither confirms nor refutes Antelman's specific claims. It did not test his material, and it says nothing about AIDS or the clinical uses described in the patents. What it does show is that silver oxides killing microbes in a dish is unremarkable and well documented, and that the published explanation for this is ordinary silver chemistry. The comparison page Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Bounded Evidence sets out where the patent assertions go beyond that baseline. Background on the oxides themselves is in Silver(I,III) Oxide and Mixed-Valence Silver Oxide.
Reference
Gudkov S.V., Serov D.A., Astashev M.E., Semenova A.A., Lisitsyn A.B. "Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation." Open access, CC BY; PMC9415021. https://pmc.ncbi.nlm.nih.gov/articles/PMC9415021/
Source notes & attribution
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9415021/